Developing an Integrated MRD Assay to Transform Oncology
Автор: Twist Bioscience
Загружено: 2025-07-31
Просмотров: 121
Описание:
In this webinar, IntegraGen and Twist Bioscience explore their collaboration on developing a tumor-informed Minimal Residual Disease (MRD) solution that’s reshaping oncology. Learn why IntegraGen chose Twist as a partner, dive into key findings from the DURIGAST study, and hear expert perspectives on MRD adoption across Europe. This session covers how high-quality sequencing, custom panels, and advanced bioinformatics are enabling better treatment monitoring and early relapse detection—bringing MRD testing closer to routine clinical use.
🔬 Topics Covered:
Why IntegraGen partnered with Twist Bioscience
Details and results from the DURIGAST study
Clinical outlook for MRD adoption in Europe
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
